Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: a case report
- PMID: 9783553
- DOI: 10.1359/jbmr.1998.13.10.1640
Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: a case report
Abstract
Multiple myeloma frequently leads to complications, such as osteolytic lesions, hypercalcemia, and pathological fractures. Increased bone resorption in myeloma is due to osteoclast activation. The nature of the osteoclast activator(s) remains unclear. We describe a case of multiple myeloma with marked hypercalcemia and skeletal complications that progressed rapidly despite chemotherapy. The patient had marked hypercalcemia at diagnosis (4.5 mmol/l), and elevated parathyroid hormone-related protein (PTHrP) levels were found in plasma. Analysis of the bone marrow trephine biopsy showed PTHrP gene transcription and protein in myeloma cells. These results provide strong evidence for the production of significant amounts of PTHrP by human myeloma cells. PTHrP has been measured as elevated in the plasma of patients with myeloma and might be an important contributor to the skeletal complications in this disease.
Similar articles
-
Assessment of cellular expression of parathyroid hormone-related protein mRNA and protein in multiple myeloma.J Pathol. 2000 Nov;192(3):336-41. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH702>3.0.CO;2-#. J Pathol. 2000. PMID: 11054717
-
Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.Horm Metab Res. 1997 Sep;29(9):469-71. doi: 10.1055/s-2007-979080. Horm Metab Res. 1997. PMID: 9370119
-
In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.J Bone Miner Res. 1995 Jan;10(1):36-44. doi: 10.1002/jbmr.5650100108. J Bone Miner Res. 1995. PMID: 7747629
-
Expression of parathyroid hormone-related protein (PTHrP) in multiple myeloma.Pathol Int. 2002 Jan;52(1):63-8. doi: 10.1046/j.1440-1827.2002.01314.x. Pathol Int. 2002. PMID: 11940209 Review.
-
Secretion of parathyroid hormone-related peptide in patients with multiple myeloma.Rev Rhum Engl Ed. 1996 Jul-Sep;63(7-8):502-3. Rev Rhum Engl Ed. 1996. PMID: 8896065 Review.
Cited by
-
Hypercalcemia of malignancy.Rev Endocr Metab Disord. 2000 Nov;1(4):253-63. doi: 10.1023/a:1026597816193. Rev Endocr Metab Disord. 2000. PMID: 11706739 Review. No abstract available.
-
Increase in serum 1,25-dihydroxyvitamin D and hypercalcaemia in a patient with inflammatory myofibroblastic tumour.J Clin Pathol. 2003 Apr;56(4):310-2. doi: 10.1136/jcp.56.4.310. J Clin Pathol. 2003. PMID: 12663647 Free PMC article.
-
Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.Endocr Connect. 2021 Jan;10(1):R13-R24. doi: 10.1530/EC-20-0487. Endocr Connect. 2021. PMID: 33289687 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials